Stephen Liu: Experience with 1000 robotic assisted lobectomies at a single center
Stephen Liu shared on X:
“Experience with 1000 robotic assisted lobectomies at a single center. Conversion to open surgery in 3.7%, minor complications in 21.3%, major complications in 2.9%. 30d mortality 0%, 90d mortality 0.1%, nodal upstaging in 17.3%.”
1000 Robotic-assisted lobectomies for primary lung cancer: 16 years single center experience
Autors: Monica Casiraghi, Andrea Cara, Antonio Mazzella, Lara Girelli, Giorgio Lo Iacono, Clarissa Uslenghi, Giovanni Caffarena, Riccardo Orlandi, Luca Bertolaccini, Patrick Maisonneuve, Lorenzo Spaggiari
Source: Stephen Liu/X
Stephen Liu is an Associate Professor of Medicine at Georgetown University, where he holds the positions of Director of Thoracic Oncology and Head of Developmental Therapeutics at the Georgetown Lombardi Comprehensive Cancer Center. As a board-certified medical oncologist specializing in lung cancer and drug development, Dr. Liu is known for his expertise in advanced thoracic malignancies. His research focuses on novel therapeutic agents and innovative combinations to improve treatment outcomes for patients with lung cancer. Dr. Liu has received multiple teaching awards and actively engages in post-graduate education initiatives. Furthermore, he co-hosts the official podcast of the International Association for the Study of Lung Cancer (IASLC), “Lung Cancer Considered”.